Financing, Equity Capital Markets

Cincor Pharma

08/22
|
$258.8 Million
Piper Sandler served as bookrunner for CinCor Pharma, Inc. on a common stock and pre-funded warrant offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma